首页 | 本学科首页   官方微博 | 高级检索  
检索        

3.0T MR扩散加权成像诊断肾透明细胞癌及短期疗效评估
引用本文:余小多,林蒙,欧阳汉,周纯武.3.0T MR扩散加权成像诊断肾透明细胞癌及短期疗效评估[J].中国医学影像技术,2010,26(4):741-744.
作者姓名:余小多  林蒙  欧阳汉  周纯武
作者单位:中国医学科学院,北京协和医学院,肿瘤医院影像诊断科,北京,100021
摘    要:目的 评价3.0T MR扩散加权成像(DWI)及ADC值在肾透明细胞癌(CCRCC)的诊断、组织学分级、肿瘤分期及短期疗效方面的价值. 方法 回顾性分析51例我院手术病理证实的CCRCC患者的术前DWI图像,测量肿瘤及对侧相应部位正常肾皮质的ADC值.以肿瘤ADC值1.8×10~(-3) mm~2/s为阈值进行分组,对两组间肿瘤组织学分级、肿瘤分期、手术方式及随诊1年内肿瘤短期控制率进行统计学检验. 结果 CCRCC及正常肾皮质的ADC值分别为(1.778±0.582)×10~(-3) mm~2/s及(2.314±0.223)×10~(-3) mm~2/s,差异有统计学意义(P<0.01).肿瘤ADC值<1.8×10~(-3) mm~2/s组24例,ADC值≥1.8×10~(-3) mm~2/s组27例,两组间组织学分级、T分期、临床分期及随诊1年内的短期肿瘤控制率差异均有统计学意义(P<0.01). 结论 DWI可以准确地区分CCRCC及正常肾皮质,定量分析ADC值有助于评估CCRCC的组织学分级、肿瘤分期及短期疗效.

关 键 词:磁共振成像    肾细胞  治疗结果
收稿时间:2009/10/8 0:00:00
修稿时间:2009/12/9 0:00:00

3.0T MR diffusion weighted imaging in diagnosis and short-term therapeutic outcome of clear cell renal cell carcinomas
YU Xiao-duo,LIN Meng,OUYANG Han and ZHOU Chun-wu.3.0T MR diffusion weighted imaging in diagnosis and short-term therapeutic outcome of clear cell renal cell carcinomas[J].Chinese Journal of Medical Imaging Technology,2010,26(4):741-744.
Authors:YU Xiao-duo  LIN Meng  OUYANG Han and ZHOU Chun-wu
Institution:Department of Diagnostic Imaging, Cancer Hospital, Peking Union Medical College, Chinese Academy of Medical Sciences, Beijing 100021, China;Department of Diagnostic Imaging, Cancer Hospital, Peking Union Medical College, Chinese Academy of Medical Sciences, Beijing 100021, China;Department of Diagnostic Imaging, Cancer Hospital, Peking Union Medical College, Chinese Academy of Medical Sciences, Beijing 100021, China;Department of Diagnostic Imaging, Cancer Hospital, Peking Union Medical College, Chinese Academy of Medical Sciences, Beijing 100021, China
Abstract:Objective To evaluate 3.0T MR diffusion weighted imaging (DWI) and ADC value in diagnosis, histological grade, tumor staging and short-time therapeutic outcome of clear cell renal cell carcinomas (CCRCC). Methods DWI of 51 patients of CCRCC confirmed with surgery and pathology were retrospectively reviewed. ADC values of tumors and the corresponding areas of lateral normal renal parenchyma were measured. Taking ADC value at 1.8×10~(-3) mm~2/s as a cut-off value, the patients were divided into two groups. The tumors' histological grade, T-staging, clinical staging, tumor short-term control rate within 1 year follow-up were compared between the two groups with statistical test. Results Statistical difference of ADC value was observed between CCRCC (1.778±0.582]×10~(-3) mm~2/s) and those of normal renal parenchyma (2.314±0.223]×10~(-3) mm~2/s) (P<0.01). ADC values of 24 patients were less than 1.8×10~(-3) mm~2/s and those of 27 patients were more than or equal to 1.8×10~(-3) mm~2/s. There were statistical differences in histological grade, T-staging, clinical staging, tumor short-term control rate within 1 year follow-up between the two groups (P<0.01). Conclusion 3.0T MR DWI can accurately differentiate CCRCC from normal renal parenchyma. Quantitative analysis of ADC value is helpful to evaluate the histological grade, tumor staging and short-term therapeutic outcome of CCRCC.
Keywords:Magnetic resonance imaging  Carcinoma  renal cell  Treatment outcome
本文献已被 CNKI 万方数据 等数据库收录!
点击此处可从《中国医学影像技术》浏览原始摘要信息
点击此处可从《中国医学影像技术》下载免费的PDF全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号